CMG Pharmaceutical Co Ltd  

(Public, KOSDAQ:058820)   Watch this stock  
Find more results for 058820
0.00 (0.00%)
Feb 17 - Close
KOSDAQ data delayed by 20 mins - Disclaimer
Currency in KRW
Range     -
52 week 1,603.74 - 8,451.03
Open     -
Vol / Avg. 500.00/1.54M
Mkt cap 377.21B
P/E     -
Div/yield     -
EPS -19.31
Shares 108.71M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 6.77% -13.50%
Operating margin 6.80% -14.27%
EBITD margin - -2.52%
Return on average assets 3.90% -6.37%
Return on average equity 4.64% -7.62%
Employees 171 -
CDP Score - -


14, Dosan-daero 66-gil, Gangnam-gu
SEOUL, 06064
South Korea
+82-31-8817612 (Phone)
+82-2-34538819 (Fax)

Website links


CMG Pharmaceutical Co., Ltd is a Korea-based company specialized in the manufacture of pharmaceuticals. The Company’s products include antibiotics, antifungals, antivirus, anti-tuberculousis drugs, peptic ulcer drugs, dementia remedies, antihistamines and antipyretics, among others. It is also engaged in the manufacture of stone products. The Company mainly distributes is pharmaceutical products within domestic markets, as well as to overseas markets. On April 16, 2013, the Company changed its name from SKYNEWPHARM. Co., Ltd to CMG Pharmaceutical Co., Ltd.

Officers and directors

Jeong Ho Kim Chief Executive Officer, Director
Age: 56
Gyeong Wuk Yoon Vice President, Director
Age: 46
Yin Su Park Internal Auditor
Age: 70
Jun Won Choi Director
Age: 48
Jong Guk Song Director
Age: 52
Tae Gyu Son Non-Executive Independent Director
Age: 60